These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8965185)

  • 1. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
    Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
    J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.
    Matochik JA; Liebenauer LL; King AC; Szymanski HV; Cohen RM; Zametkin AJ
    Am J Psychiatry; 1994 May; 151(5):658-64. PubMed ID: 8166305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
    J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
    Ernst M; Zametkin AJ; Matochik JA; Liebenauer L; Fitzgerald GA; Cohen RM
    Psychopharmacol Bull; 1994; 30(2):219-25. PubMed ID: 7831459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
    Rottenberg DA; Sidtis JJ; Strother SC; Schaper KA; Anderson JR; Nelson MJ; Price RW
    J Nucl Med; 1996 Jul; 37(7):1133-41. PubMed ID: 8965184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.
    Matochik JA; Nordahl TE; Gross M; Semple WE; King AC; Cohen RM; Zametkin AJ
    Neuropsychopharmacology; 1993 Jun; 8(4):377-86. PubMed ID: 8512624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
    Zametkin AJ; Liebenauer LL; Fitzgerald GA; King AC; Minkunas DV; Herscovitch P; Yamada EM; Cohen RM
    Arch Gen Psychiatry; 1993 May; 50(5):333-40. PubMed ID: 8489322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
    Fulham MJ; Brunetti A; Aloj L; Raman R; Dwyer AJ; Di Chiro G
    J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects.
    Ernst M; Zametkin AJ; Phillips RL; Cohen RM
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):168-77. PubMed ID: 9608405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in cerebellar metabolism: test-retest reproducibility.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Pappas N; Pascani K; Wong C
    Am J Psychiatry; 1997 Jan; 154(1):119-21. PubMed ID: 8988972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous dextroamphetamine and brain glucose metabolism.
    Ernst M; Zametkin AJ; Matochik J; Schmidt M; Jons PH; Liebenauer LL; Hardy KK; Cohen RM
    Neuropsychopharmacology; 1997 Dec; 17(6):391-401. PubMed ID: 9397427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography.
    Tyler JL; Strother SC; Zatorre RJ; Alivisatos B; Worsley KJ; Diksic M; Yamamoto YL
    J Nucl Med; 1988 May; 29(5):631-42. PubMed ID: 3259623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H; Gjedde A
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral glucose metabolic differences in patients with panic disorder.
    Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
    Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.